CALL US NOW 0207 939 0780
PLEASE DONATE

Tagged as: hepatitis C

Response to the Contaminated Blood Announcement and Consultation

Overview The Department of Health (DH) today published a written ministerial statement announcing some changes to the support scheme for people affected by contaminated blood and launching a new consultation on the Special Category Mechanism and the discretionary support scheme. The consultation will run for six weeks, until the 17th

Read More

Direct-acting Antiviral (DAA) treatment for Hepatitis C risks Hepatitis B reactivation

New guidance from the Medicines and Healthcare products Regulatory Agency (MHRA) advises that all hepatitis C patients should be screened for hepatitis B before starting treatment with new Direct-acting Antivirals (DAAs). If patients are infected with both viruses this does not preclude treatment but this should be monitored and managed.

Read More